Development of an Unsupervised Pixel-based Clustering Algorithm for Compartmentalization of Immunohistochemical Expression Using Automated QUantitative Analysis

被引:28
作者
Gustavson, Mark D. [1 ]
Bourke-Martin, Brian [1 ]
Reilly, Dylan M. [1 ]
Cregger, Melissa [1 ]
Williams, Christine [1 ]
Tedeschi, Greg [1 ]
Pinard, Robert [1 ]
Christiansen, Jason [1 ]
机构
[1] HistoRx Inc, New Haven, CT 06511 USA
来源
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | 2009年 / 17卷 / 04期
关键词
quantitative immunohistochemistry; unsupervised image analysis; biomarkers; PROTEIN EXPRESSION; TISSUE MICROARRAYS; CANCER; BREAST; SHOWS; LOCALIZATION; PROGNOSIS; PREDICTOR; CARCINOMA; THERAPY;
D O I
10.1097/PAI.0b013e318195ecaa
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100123 [人体微生态学]; 100210 [外科学];
摘要
Inherent to most tissue image analysis routines are user-defined steps whereby specific pixel intensity thresholds must be set manually to differentiate background from signal-specific pixels within multiple images. To reduce operator time, remove operator-to-operator variability, and to obtain objective and optimal pixel separation for each image, we have developed art unsupervised pixel-based clustering algorithm allowing for the objective and unsupervised differentiation of signal from background, and differentiation of compartment-specific pixels on an image-by-image basis. We used the Automated QUantitative Analysis (AQUA) platform, a well-established automated fluorescence-based immunohistochemistry image analysis platform used for quantification of protein expression in specific cellular compartments to demonstrate utility of this methodology. As a metric for cellular compartmentalization, we examined correlation of percentage nuclear volume with histologic grade in 3 serial sections of a large cohort (n = 669) of invasive breast cancer samples. We observed a significant (P = 0.002, 0.006, and 0.08) difference in mean percentage nuclear volume between low and high-grade tumors. Reproducibility of percentage nuclear volume was also significant (P < 0.001) across 3 serial sections. We then quantified compartment-specific expression of 5 biomarkers in 3 cancer types for association with outcome: estrogen receptor (nuclear), progesterone receptor (nuclear), HER2 (membrane/cytoplasm), ERCC1 (nuclear), and PTEN (cytoplasm). All 5 markers showed an expected and significant (P < 0.05) association with survival. This new clustering algorithm thus produces accurate and precise compartmentalization for assessment of target gene expression, and will enhance the efficiency and objectivity of the current Automated QUantitative Analysis and other image analysis platform.
引用
收藏
页码:329 / 337
页数:9
相关论文
共 19 条
[1]
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases [J].
Bardou, VJ ;
Arpino, G ;
Elledge, RM ;
Osborne, CK ;
Clark, GM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) :1973-1979
[2]
Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome [J].
Berger, AJ ;
Camp, RL ;
DiVito, KA ;
Kluger, HM ;
Halaban, R ;
Rimm, DL .
CANCER RESEARCH, 2004, 64 (23) :8767-8772
[3]
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[4]
Camp RL, 2003, CANCER RES, V63, P1445
[5]
Automated subcellular localization and quantification of protein expression in tissue microarrays [J].
Camp, RL ;
Chung, GG ;
Rimm, DL .
NATURE MEDICINE, 2002, 8 (11) :1323-1327
[6]
Cregger M, 2006, ARCH PATHOL LAB MED, V130, P1026
[7]
Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594
[8]
Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome [J].
Dolled-Filhart, Marisa ;
McCabe, Anthony ;
Giltnane, Jennifer ;
Cregger, Melissa ;
Camp, Robert L. ;
Rimm, David L. .
CANCER RESEARCH, 2006, 66 (10) :5487-5494
[9]
Giltnane JM, 2004, NAT CLIN PRACT ONCOL, V1, P104, DOI 10.1038/ncponc0046
[10]
Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and, predicts outcome [J].
Hsu, CY ;
Kurman, RJ ;
Vang, R ;
Wang, TL ;
Baak, J ;
Shih, IM .
HUMAN PATHOLOGY, 2005, 36 (10) :1049-1054